← Back to all trials
Completed
NCT07933380
A Case Study to Assess a Brightening Skincare Regimen in Patients With Bothersome Skin Dark Spots
Conditions: Post - Inflammatory Hyperpigmentation, Pigmentation
Sex: Female
Ages: 25 Years – 55 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 7
Sponsor: Revision Skincare
Location: REVE Dermatology and Aesthetics The Woodlands Texas
Summary
This 12- week, single-center, open-label case study is being conducted to assess the efficacy and tolerance of a brightening skincare regimen comprised of a facial wash, brightening serum, brightening exfoliating pads, face cream and sunscreen by healthy females with clinically determined mild to moderate Post-inflammatory hyperpigmentation (PIH).
Eligibility Criteria
Inclusion Criteria:
* Female (biological), 25 to 55 years of age
* Having Fitzpatrick skin type I-VI (refer to Appendix I: Fitzpatrick Skin Type)
* Having mild to moderate Post-Inflammatory Hyperpigmentation as identified as a grade 2 or 3 on the 5-point Investigator Global Assessment Scale \[ 0 = clear, 1 = Almost Clear, 2 = Mild, 3 = Moderate, 4 = Severe\]
* Having active Post-Inflammatory Hyperpigmentation due to blemish-prone skin with no active breakouts within the last 3 months
* Having active PIH due to sun exposure, rosacea, and procedures
* Self-perceived very bothersome hyperpigmentation (darkening), including spots, on the global face
* In good general health (physical, mental, and social well-being, not merely the absence of disease/infirmity), according to subject self-report.
Exclusion Criteria:
* Breastfeeding, pregnancy, or planning to become pregnant
* Having been diagnosed with known allergies to skin care products
* Having a known reactivity to tranexamic acid, niacinamide, sunflower seed, coconut, rosemary, barley, goji, sandalwood, licorice root, radish root, beeswax, yeast, ascorbic acid, tetrahexyldecyl ascorbate, and/or any of the ingredients in the study products
* Having a health condition and/or pre-existing or dormant dermatologic disease on the face
Source: ClinicalTrials.gov (NCT07933380). StuddyBuddy aggregates publicly available trial information.